(Q42490163)

1 November 2017

title

Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruption (English)

1 reference

1 November 2017

0 references

Choi HJ

1

1 reference

1 November 2017

Ku JK

2

1 reference

1 November 2017

Kim MY

3

1 reference

1 November 2017

Kang H

4

1 reference

1 November 2017

Cho SH

5

1 reference

1 November 2017

Kim HO

6

1 reference

1 November 2017

Park YM

7

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

British Journal of Dermatology

1 November 2017

published in

1 reference

1 November 2017

volume

154

1 reference

1 November 2017

issue

3

1 reference

1 November 2017

page(s)

419-425

1 reference

IFN-gamma-producing effector CD8+ T cells and IL-10-producing regulatory CD4+ T cells in fixed drug eruption

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07057.X

Death receptors in cutaneous biology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07057.X

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07057.X

The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07057.X

Molecular mechanisms of caspase regulation during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07057.X

Direct evidence for interferon-gamma production by effector-memory-type intraepidermal T cells residing at an effector site of immunopathology in fixed drug eruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07057.X

Pathophysiology of fixed drug eruption: the role of skin-resident T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07057.X

Intracellular localization of keratinocyte Fas ligand explains lack of cytolytic activity under physiological conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07057.X

Successful desensitization to fixed drug eruption: the presence of CD25+CD4+ T cells in the epidermis of fixed drug eruption lesions may be involved in the induction of desensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07057.X

Epidermal T cells: their functional role and disease relevance for dermatologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07057.X

Fas transduces activation signals in normal human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07057.X

Development of inflammatory angiogenesis by local stimulation of Fas in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07057.X

Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07057.X

Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07057.X

Immunohistology of drug-induced exanthema: clues to pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07057.X

Pathogenesis of drug-induced exanthema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07057.X

10.1111/J.1365-2133.2005.07057.X

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference